Results of this study showed that combination of metformin and tenovin‐6 acted synergistically in inhibiting cell growth in NSCLC cells irrespective of LKB1 status through inhibition of SIRT1 expression. This evidence concerns the gene STK11 and non-small cell lung carcinoma.